{"Title": "Association of Plasma and Urinary Mutant DNA with Clinical Outcomes in Muscle Invasive Bladder Cancer", "Year": 2017, "Source": "Sci. Rep.", "Volume": "7", "Issue": 1, "Art.No": null, "PageStart": null, "PageEnd": null, "CitedBy": 29, "DOI": "10.1038/s41598-017-05623-3", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85025164805&origin=inward", "Abstract": "\u00a9 2017 The Author(s).Muscle Invasive Bladder Cancer (MIBC) has a poor prognosis. Whilst patients can achieve a 6% improvement in overall survival with Neo-Adjuvant Chemotherapy (NAC), many do not respond. Body fluid mutant DNA (mutDNA) may allow non-invasive identification of treatment failure. We collected 248 liquid biopsy samples including plasma, cell pellet (UCP) and supernatant (USN) from spun urine, from 17 patients undergoing NAC. We assessed single nucleotide variants and copy number alterations in mutDNA using Tagged-Amplicon-A nd shallow Whole Genome-Sequencing. MutDNA was detected in 35.3%, 47.1% and 52.9% of pre-NAC plasma, UCP and USN samples respectively, and urine samples contained higher levels of mutDNA (p = <0.001). Longitudinal mutDNA demonstrated tumour evolution under the selective pressure of NAC e.g. in one case, urine analysis tracked two distinct clones with contrasting treatment sensitivity. Of note, persistence of mutDNA detection during NAC predicted disease recurrence (p = 0.003), emphasising its potential as an early biomarker for chemotherapy response.", "AuthorKeywords": null, "IndexKeywords": ["Aged", "DNA, Neoplasm", "Female", "Follow-Up Studies", "Genome, Human", "Humans", "Male", "Middle Aged", "Mutation", "Neoadjuvant Therapy", "Neoplasm Recurrence, Local", "Treatment Outcome", "Urinary Bladder Neoplasms"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85025164805", "SubjectAreas": [["Multidisciplinary", "MULT", "1000"]], "AuthorData": {"56581061100": {"Name": "Patel K.M.", "AuthorID": "56581061100", "AffiliationID": "60031101", "AffiliationName": "Academic Urology Group, Department of Surgery and Oncology, University of Cambridge"}, "57216536923": {"Name": "Smith C.G.", "AuthorID": "57216536923", "AffiliationID": "60031101, 60012754", "AffiliationName": "Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre"}, "36630830500": {"Name": "Mouliere F.", "AuthorID": "36630830500", "AffiliationID": "60031101, 60012754", "AffiliationName": "Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre"}, "23096203700": {"Name": "Tsui D.", "AuthorID": "23096203700", "AffiliationID": "60031101, 60012754", "AffiliationName": "Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre"}, "57188975808": {"Name": "Morris J.", "AuthorID": "57188975808", "AffiliationID": "60031101, 60012754", "AffiliationName": "Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre"}, "56157012000": {"Name": "Chandrananda D.", "AuthorID": "56157012000", "AffiliationID": "60031101, 60012754", "AffiliationName": "Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre"}, "35519967000": {"Name": "Marass F.", "AuthorID": "35519967000", "AffiliationID": "60031101, 60012754", "AffiliationName": "Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre"}, "35393852700": {"Name": "Neal D.E.", "AuthorID": "35393852700", "AffiliationID": "60002634, 60026851", "AffiliationName": "Nuffield Department of Surgery, University of Oxford"}, "6506634124": {"Name": "Forshew T.", "AuthorID": "6506634124", "AffiliationID": "60109234", "AffiliationName": "UCL Cancer Institute"}, "24481863300": {"Name": "Massie C.E.", "AuthorID": "24481863300", "AffiliationID": "60031101, 60012754", "AffiliationName": "Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre"}, "6604022727": {"Name": "Rosenfeld N.", "AuthorID": "6604022727", "AffiliationID": "60031101, 60012754", "AffiliationName": "Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre"}, "57211450109": {"Name": "Gnanapragasam V.J.", "AuthorID": "57211450109", "AffiliationID": "60031101", "AffiliationName": "Academic Urology Group, Department of Surgery and Oncology, University of Cambridge"}, "16200095700": {"Name": "Van Der Vos K.E.", "AuthorID": "16200095700", "AffiliationID": "60015205", "AffiliationName": "Division of Molecular Carcinogenesis, Netherlands Cancer Institute"}, "7005587639": {"Name": "Van Der Heijden M.S.", "AuthorID": "7005587639", "AffiliationID": "60015205", "AffiliationName": "Department of Medical Oncology, Netherlands Cancer Institute"}, "6507095171": {"Name": "Van Den Broek D.", "AuthorID": "6507095171", "AffiliationID": "60015205", "AffiliationName": "Department of Clinical Chemistry, Netherlands Cancer Institute"}, "6602152865": {"Name": "Van Rhijn B.W.", "AuthorID": "6602152865", "AffiliationID": "60015205", "AffiliationName": "Department of Surgical Oncology, Netherlands Cancer Institute"}}}